mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to Chemotherapy
Conditions: Pancreatic Cancer; Radiotherapy Interventions: Drug: mFOLFIRINOX plus IMRT Sponsors: Fudan University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Intensity-Modulated Radiation Therapy | Pancreas | Pancreatic Cancer | Research